Patent challenges to antibody and gene-therapy firms on the rise

Nat Biotechnol. 2018 May 9;36(5):382-383. doi: 10.1038/nbt0518-382.
No abstract available

MeSH terms

  • Antibodies / therapeutic use*
  • Genetic Therapy / legislation & jurisprudence*
  • Humans
  • Patents as Topic / legislation & jurisprudence*
  • United States

Substances

  • Antibodies